BR0005061A - Secreção de ácido gástrico - Google Patents

Secreção de ácido gástrico

Info

Publication number
BR0005061A
BR0005061A BR0005061-0A BR0005061A BR0005061A BR 0005061 A BR0005061 A BR 0005061A BR 0005061 A BR0005061 A BR 0005061A BR 0005061 A BR0005061 A BR 0005061A
Authority
BR
Brazil
Prior art keywords
gastric acid
acid secretion
processes
animals
exacerbated
Prior art date
Application number
BR0005061-0A
Other languages
English (en)
Inventor
Roelof Marthinus Horak
Vinesh Maharaj
John Hakkinen
Original Assignee
Phytopharm Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharm Plc filed Critical Phytopharm Plc
Publication of BR0005061A publication Critical patent/BR0005061A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"SECREçãO DE áCIDO GáSTRICO". O presente pedido de patente refere-se à redução de secreção de ácido gástrico em animais incluindo humanos; a processos de tratamento de condições ou desordens associadas com ou exacerbadas por secreção de ácido gástrico; a composições farmacêuticas úteis em realização de tais processos; e ao uso de certos extratos e compostos no tratamento de animais não-humanos e humanos, genericamente mamíferos.
BR0005061-0A 1999-10-27 2000-10-26 Secreção de ácido gástrico BR0005061A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9925457A GB2355657B (en) 1999-10-27 1999-10-27 Inhibitors Of Gastric Acid Secretion

Publications (1)

Publication Number Publication Date
BR0005061A true BR0005061A (pt) 2004-03-23

Family

ID=10863497

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0005061-0A BR0005061A (pt) 1999-10-27 2000-10-26 Secreção de ácido gástrico

Country Status (8)

Country Link
US (3) US6488967B1 (pt)
EP (1) EP1099444A1 (pt)
JP (1) JP2001158741A (pt)
BR (1) BR0005061A (pt)
CA (1) CA2324538A1 (pt)
GB (2) GB2355657B (pt)
MX (1) MXPA00010525A (pt)
ZA (1) ZA200006045B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2283564C (en) * 1997-04-15 2007-07-10 Csir Pharmaceutical compositions having appetite suppressant activity
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
CN101505771A (zh) * 2006-08-17 2009-08-12 荷兰联合利华有限公司 含有甾体糖苷的hoodia植物萃取物的制造方法
WO2010092467A1 (en) * 2009-02-13 2010-08-19 Carlo Ghisalberti Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder
EP2329836A1 (en) 2009-12-03 2011-06-08 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from hoodia gordonii cells lines, their preparation and use
WO2012022880A2 (fr) 2010-07-29 2012-02-23 Universite De Strasbourg Procede de synthese de steroïdes

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3463852A (en) * 1966-01-14 1969-08-26 Schering Corp Treating allergies with steroids of the pregnane series
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
FR2348655A1 (fr) * 1976-04-20 1977-11-18 Sopharga Lab Nouvelle substance alimentaire ou dietetique ayant une structure alveolaire et son procede de preparation
US4185116A (en) * 1976-09-28 1980-01-22 Pfizer Inc. L- and DL- Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism
USPP4199P (en) 1977-01-18 1978-01-24 B. L. Cobia, Inc. Milkweed plant family
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS5953920B2 (ja) * 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4791126A (en) * 1980-08-22 1988-12-13 Ono Pharmaceutical Co., Ltd. Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DE3166093D1 (en) * 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
CA1176269A (en) * 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
US4377500A (en) 1981-07-08 1983-03-22 The Standard Oil Co. Catalysts
US4436745A (en) * 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4438272A (en) * 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
JPS58194818A (ja) 1982-05-10 1983-11-12 Iwasaki Shuzo サボテン中の水溶性多糖及び繊維の取得方法
ES524614A0 (es) * 1982-08-12 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos amino-14 esteroides.
AU570439B2 (en) 1983-03-28 1988-03-17 Compression Labs, Inc. A combined intraframe and interframe transform coding system
HU201675B (en) 1983-08-26 1990-12-28 Ivan Balkanyi Process for producing oral pharmaceutical compositions with unappetizing effect
US5066659A (en) * 1984-10-30 1991-11-19 Pfizer Inc. Spiro-heteroazalones for treatment of diabetic complications
US4634765A (en) * 1984-12-18 1987-01-06 Merrell Dow Pharmaceuticals Inc. Homodisaccharide hypoglycemic agents
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
US5246960A (en) * 1984-12-21 1993-09-21 Hoffmann-La Roche Inc. Oxetanones
IT1207504B (it) 1985-09-26 1989-05-25 Crinos Industria Farmaco Composizione moderatrice dell'appetito ed antigastrica.
IT1190400B (it) 1985-10-04 1988-02-16 Istituto Biochimico Italiano Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4757151A (en) 1985-11-14 1988-07-12 Warner-Lambert Company 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
US4652553A (en) * 1985-11-25 1987-03-24 Merck & Co., Inc. Steroidal glycolipids as host resistance stimulators
GB8600489D0 (en) * 1986-01-09 1986-02-12 Erba Farmitalia Aminoglycoside steroids
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use
EP0264586B1 (en) * 1986-08-28 1991-04-03 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin derivatives for treating complications of diabetes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
ZA883929B (en) 1987-06-22 1990-02-28 Hoffmann La Roche Cholecystokinin analogs for controlling appetite
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
GB8801037D0 (en) * 1988-01-18 1988-02-17 Plessey Co Ltd Improvements relating to fuel supply systems
US5252572A (en) * 1988-02-03 1993-10-12 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
DE3836675A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung
US4978669A (en) 1989-06-08 1990-12-18 Neurex Corporation Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives
JPH03120227A (ja) * 1989-10-02 1991-05-22 Shigeo Ochi 飲食物消化分解産物吸収抑制剤
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
US5504078A (en) * 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
GB9016978D0 (en) * 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
US5091418A (en) * 1990-09-28 1992-02-25 Bristol-Myers Squibb Company Novel alpha-glucosidase inhibitor, pradimicin Q
US5217877A (en) * 1990-09-28 1993-06-08 Bristol-Myers Squibb Company Process for the preparation of α-glucosidase inhibitor, pradimicin Q
US6100048A (en) 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
AU683620B2 (en) * 1992-09-28 1997-11-20 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
DE69332474T2 (de) 1992-09-30 2003-07-17 Motorola, Inc. Verlässliches nachrichtenablieferungssystem
GB9307833D0 (en) 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
FR2706255B1 (fr) 1993-06-17 1995-10-27 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
JPH11501281A (ja) 1993-06-18 1999-02-02 ユニバーシティ オブ シンシナティ 神経ペプチドｙアンタゴニスト及びアゴニスト
US5516516A (en) * 1993-10-19 1996-05-14 Cherksey; Bruce D. Method of preparing muira puama extract and its use for decreasing body fat percentage and increasing lean muscle mass
JPH07184548A (ja) * 1993-12-28 1995-07-25 Meiji Seito Kk 口腔用組成物
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5698199A (en) * 1995-03-10 1997-12-16 Kao Corporation Lipolysis acceleration method
ATE206702T1 (de) 1995-06-06 2001-10-15 Pfizer Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren
DK0832066T3 (da) 1995-06-06 2001-11-19 Pfizer Substituerede N-(indol-2-carbonyl)amider og derivater som glycogenphosphorylaseinhibitorer
JPH08332028A (ja) 1995-06-12 1996-12-17 Takashi Mizuno サボテン成分入り冷菓とその製法
US5693327A (en) * 1995-07-12 1997-12-02 Shah; Eladevi Herbal compositions
CA2238940A1 (en) 1995-10-26 1997-05-01 Board Of Regents, The University Of Texas System Luminal cholecystokinin-releasing factor
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
EP0776667A3 (en) * 1995-11-30 1997-08-20 Nippon Mektron Kk Antiulcer agent
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
EP1231218B1 (en) 1996-03-01 2008-05-14 Novo Nordisk A/S An appetite-suppressing peptide, its compositions and use
US5908609A (en) * 1996-06-10 1999-06-01 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight
US5932779A (en) 1996-06-10 1999-08-03 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight
AU5243798A (en) 1996-11-06 1998-05-29 Children's Medical Center Corporation Transgenic animal expressing a syndecan in the regions of hypothalamus
CN1246868A (zh) 1996-12-17 2000-03-08 扇形支撑剑桥有限公司 黑皮素
CA2217698A1 (en) 1996-12-20 1998-06-20 Eli Lilly And Company Anti-obesity proteins
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
JP2002538757A (ja) 1997-03-26 2002-11-12 ノボ ノルディスク アクティーゼルスカブ 食欲制御活性を有するポリペプチド
CA2283564C (en) * 1997-04-15 2007-07-10 Csir Pharmaceutical compositions having appetite suppressant activity
FR2771105A1 (fr) 1997-11-20 1999-05-21 Vitasterol Utilisation du fusarium monoliforme pour la preparation des derives 7alpha-hydroxyles de la dehydroepiandrosterone et de la pregnenolone
HUP9803039A2 (hu) 1998-12-30 2000-09-28 István Lelkes Az elhízás kezelésére, megelőzésére, szövődményei kialakulásának kivédésére, a kialakult szövődmények kezelésére szolgáló gyógyászati kompozíció
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use

Also Published As

Publication number Publication date
EP1099444A1 (en) 2001-05-16
GB9925457D0 (en) 1999-12-29
ZA200006045B (en) 2001-05-03
MXPA00010525A (es) 2002-07-09
US7501135B2 (en) 2009-03-10
CA2324538A1 (en) 2001-04-27
US6808723B2 (en) 2004-10-26
GB2396815B (en) 2004-09-08
GB0408783D0 (en) 2004-05-26
GB2396815A (en) 2004-07-07
JP2001158741A (ja) 2001-06-12
US20050079233A1 (en) 2005-04-14
GB2355657B (en) 2004-07-28
US20020192306A1 (en) 2002-12-19
US6488967B1 (en) 2002-12-03
GB2355657A (en) 2001-05-02

Similar Documents

Publication Publication Date Title
BR0214736A (pt) Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições
WO2001045679A3 (de) Verwendung von chemotherapeutika zur topischen behandlung
MA23533A1 (fr) Formes posologiques d'azithromycine
BR9909730A (pt) Dihidropirimidinas
ATE374029T1 (de) Behandlung der alzheimer-krankheit durch erhöhung des cytidin-spiegels in vivo
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
MY101842A (en) Treatment of oral diseases.
ATE132747T1 (de) Sprays zur behandlung von infektionen des tractus respiratorius
BR9911094A (pt) Composições e métodos para o tratamento detosse
BR9913441A (pt) Derivados do ácido tiazolìnico
PL354216A1 (en) Application of thyromimetic compounds in production of a drug and a pharmacological agent for use in that production
BRPI0016231B8 (pt) composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo
MX9704775A (es) Formulaciones reductoras de irritacion de la piel y su uso.
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
BR0005061A (pt) Secreção de ácido gástrico
HUP0101817A2 (hu) 15 tagú laktám ketolidok és ezeket tartalmazó antibakteriális hatású gyógyszerkészítmények
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
ZA965856B (en) Fungicidal mixtures.
BR0211830A (pt) Dose única de azitromicina
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
RS8504A (en) Novel cyclohexil sulphones
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
BR0109496A (pt) Uso de bactéria do ácido láctico para o tratamento de peritonite

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: UNILEVER NV (NL)

Free format text: TRANSFERIDO DE: PHYTOPHARM PLC

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/704 (2006.01), A61K 31/57 (2006.01), A61K

B11T Dismissal of application maintained [chapter 11.20 patent gazette]